Affinity Asset Advisors, LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1773195
NEW YORK, NY
Position in TEVA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$42,168,000
-$1,526,000 QoQ
Shares Held
1,400,000
0.0% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
2.55%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Derivatives in TEVA
reported options exposure · as of Sep 30, 2024CallValue
$18,020,000
CallShares
1,000,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Affinity Asset Advisors, LLC holds $89,904,000 across 2 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (46.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
1,350,000 | $47,736,000 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
1,400,000 | $42,168,000 |
All Filings in TEVA
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $42,168,000 | 1,400,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $43,694,000 | 1,400,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $28,280,000 | 1,400,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $23,464,000 | 1,400,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $21,518,000 | 1,400,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $30,856,000 | 1,400,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $18,020,000 | 1,000,000 | Call | Sole | 2024-11-13 | |
| 2024-09-30 | $25,228,000 | 1,400,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $23,562,500 | 1,450,000 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $18,687,500 | 1,150,000 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $19,754,000 | 1,400,000 | Shares | Sole | 2024-05-14 | |
| 2024-03-31 | $23,352,050 | 1,655,000 | Call | Sole | 2024-05-14 | |
| 2023-12-31 | $14,616,000 | 1,400,000 | Call | Sole | 2024-02-13 | |
| 2023-12-31 | $19,836,000 | 1,900,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $20,400,000 | 2,000,000 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $11,220,000 | 1,100,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $12,048,000 | 1,600,000 | Shares | Sole | 2023-08-21 | |
| No filing history on record for this holder in this stock. | ||||||